<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">23061</article-id><article-id pub-id-type="doi">10.7554/eLife.23061</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Modelling primaquine-induced haemolysis in G6PD deficiency</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-63402"><name><surname>Watson</surname><given-names>James</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5524-0325</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74086"><name><surname>Taylor</surname><given-names>Walter RJ</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74088"><name><surname>Menard</surname><given-names>Didier</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1357-4495</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74087"><name><surname>Kheng</surname><given-names>Sim</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35051"><name><surname>White</surname><given-names>Nicholas J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1897-1978</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine</institution>, <institution>Mahidol University</institution>, <addr-line><named-content content-type="city">Bangkok</named-content></addr-line>, <country>Thailand</country></aff><aff id="aff2"><institution content-type="dept">Unité d'Epidémiologie Moléculaire du Paludisme</institution>, <institution>Institut Pasteur du Cambodge</institution>, <addr-line><named-content content-type="city">Phnom Penh</named-content></addr-line>, <country>Cambodia</country></aff><aff id="aff3"><institution>National Center for Parasitology, Entomology and Malaria Control</institution>, <addr-line><named-content content-type="city">Phnom Penh</named-content></addr-line>, <country>Cambodia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1017"><name><surname>Jha</surname><given-names>Prabhat</given-names></name><role>Reviewing editor</role><aff><institution>Saint Michael's Hospital</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jwatowatson@gmail.com</email> (JW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>02</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e23061</elocation-id><history><date date-type="received"><day>10</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>31</day><month>01</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Watson et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Watson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-23061-v1.pdf"/><abstract><p>Primaquine is the only drug available to prevent relapse in vivax malaria. The main adverse effect of primaquine is erythrocyte age and dose dependent acute haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). As testing for G6PDd is often unavailable this limits the use of primaquine for radical cure. A compartmental model of the dynamics of red blood cell production and destruction was designed to characterise primaquine-induced haemolysis using a holistic Bayesian analysis of all published data and was used to predict a safer alternative to the currently recommended once weekly 0.75mg/kg regimen for G6PDd. The model suggests that a step-wise increase in daily administered primaquine dose would be relatively safe in G6PDd. If this is confirmed then were this regimen to be recommended for radical cure patients would not require testing for G6PDd  in areas where G6PD Viangchan or milder variants are prevalent.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Watson</surname><given-names>James</given-names></name><name><surname>Taylor</surname><given-names>Walter RJ</given-names></name><name><surname>White</surname><given-names>Nicholas J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-23061-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>